Long Non-Coding RNAs in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, and Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long Non-Coding RNAs in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, and Therapy

Published:2019 Issue:3 Volume:42 Page:136-142
ISSN:2296-5270
Container-title:Oncology Research and Treatment
language:en
Short-container-title:Oncol Res Treat

Author:

Mahmoudian-Sani Mohammad-Reza,Jalali Akram,Jamshidi Mohammad,Moridi Heresh,Alghasi Arash,Shojaeian Ali,Mobini Gholam-Reza

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,Hematology

Reference73 articles.

1. Carling T, Udelsman R: Thyroid cancer. Annu Rev Med 2014;65:125-137.

2. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R: Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013;2013:965212.

3. Grewal RK, Ho A, Schoder H: Novel approaches to thyroid cancer treatment and response assessment. Semin Nucl Med 2016;46:109-118.

4. Schneider DF, Chen H: New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin 2013;63:374-394.

5. Kung JT, Colognori D, Lee JT: Long noncoding RNAs: past, present, and future. Genetics 2013;193:651-669.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the Role of Non-Coding RNAs as Regulators in the Wound Healing Process;Journal of Wound Management and Research;2024-06-30

2. LINC02454 promotes thyroid carcinoma progression via upregulating HMGA2 through CREB1;The FASEB Journal;2023-11-23

3. LINC00092 Enhances LPP Expression to Repress Thyroid Cancer Development via Sponging miR-542-3p;Hormone and Metabolic Research;2023-11-07

4. LncRNA PFAR facilitates the proliferation and migration of papillary thyroid carcinoma by competitively binding to miR-15a;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-10-24

5. Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells;Frontiers in Pharmacology;2023-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3